Navigation Links
Transdel Pharmaceuticals Enters Into License Agreement with JH Direct, LLC for Cosmeceutical Product
Date:6/10/2009

Agreement Includes Exclusive Worldwide License to Transdel's Anti-Cellulite Cosmeceutical Product

LA JOLLA, Calif., June 10 /PRNewswire-FirstCall/ -- Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP) and JH Direct, LLC have entered into a licensing agreement providing JH Direct with the exclusive worldwide rights to Transdel's anti-cellulite cosmeceutical product which utilizes Transdel's patented transdermal delivery system technology, Transdel(TM). The licensing agreement between Transdel and JH Direct is a significant milestone for Transdel as it is the first agreement involving the use of Transdel's proprietary technology for a cosmeceutical product. Transdel plans to further develop its pipeline of cosmetic/cosmeceutical products.

Under the terms of the agreement, JH Direct will pay Transdel initial royalty advances and a continuing licensing royalty on the worldwide sales of the anti-cellulite product. The product will be launched through direct response television campaigns, created and managed by JH Direct, followed by an expansion into traditional channels of distribution, such as retail or wholesale channels. Transdel has retained the exclusive rights to seek pharmaceutical/dermatological partners for the anti-cellulite product for an initial period of one year, thereafter JH Direct will be allowed to expand in this channel.

"We are extremely pleased with our relationship with JH Direct and plan on building on this relationship to launch additional cosmeceutical products. This venture is very exciting as we believe it could represent the beginning of what may become a revenue stream for Transdel. An estimated 85% to 90% of women develop cellulite following puberty. The size of this target market combined with the desire to remove cellulite represents a $3 billion market and thus provides a promising market opportunity," stated Dr. Juliet Singh, President and Chief Executive Office
'/>"/>

SOURCE Transdel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Transdel Pharmaceuticals, Inc. Featured on National Broadcast Television
2. Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities
3. Transdel Expands Program to Include Cosmetic/Cosmeceutical Products
4. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
5. Transdel Pharmaceuticals to Present at Cowen and Companys 28th Annual Health Care Conference
6. Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia
7. Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit
8. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
9. Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
10. Metastorm Customer, Wyeth Pharmaceuticals, Wins CIO 100 Award for BPM Project
11. Endo Pharmaceuticals to Present at Goldman Sachs 30th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... variant specifically associated with the risk of a ... cent of all breast cancer cases. , The ... called invasive lobular carcinoma, gives researchers important clues ... of breast cancer, which can be missed through ... the journal PloS Genetics , was co-led ...
(Date:4/17/2014)... San Diego School of Medicine report that older women, ... major loss are more likely to be compassionate toward ... published in this month,s issue of the International ... are associated with better health and well-being as we ... improve the outcomes of individuals whose deficits in compassion ...
(Date:4/17/2014)... personnel who served in Iraq and Afghanistan and ... (TBI) were compared to military personnel without TBI ... in measures of overall disability, cognitive function, post-traumatic ... reported in an article in Journal of ... Liebert, Inc., publishers. The article is available free ...
(Date:4/17/2014)... 2014 By discovering a new mechanism that allows ... researchers at UC Irvine and the Salk Institute have ... or prevent stroke-induced brain damage. , A complex and ... death and primary reason for disability in the U.S. ... and lets blood-borne material into the brain, causing the ...
(Date:4/17/2014)... international research team led by Cesar A. Arias, M.D., ... at Houston (UTHealth) has identified a new superbug that ... report appeared in the April 17 issue of ... new superbug is part of a class of highly-resistant ... MRSA, which is a major cause of hospital and ...
Breaking Medicine News(10 mins):Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:The ilk of human kindness 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:New MRSA superbug emerges in Brazil 2
... who eat fish or seafood at least once a week have ... studied a group of 1205 people aged over 65 //and without ... consuming meat, fish and seafood, then followed them up to, five ... seafood at least once a week had a significantly lower risk ...
... the latest study done by the researchers of University of ... the cause if you have abdominal pain, gas and diarrhea.// ... and diarrhea and no obvious reason can be found. They ... with these symptoms may be unable to digest fructose. ...
... study it is indicative that systolic blood pressure is ... with impaired consciousness. This means doctors may now have ... using expensive and time-consuming imaging technology. ,Researchers studied ... to an emergency room with impaired consciousness. Of the ...
... University observed that anomalies in the part of the brain ... Recent studies have linked facial// recognition to a part of ... both the left and right sides of the brain. This ... seeing and also what they may be thinking or feeling ...
... for early outset glaucoma appears to slow the advancement of ... form of glaucoma appears to impact the progression of vision ... to detect it only in a detailed eye exam. In ... glaucoma in one eye. Around half of the group was ...
... to a new study it is observed that reducing blood ... half. It is already known that hypertension (high blood pressure) ... a study carried out by doctors in Dallas, the effect ... ,A group of patients with systolic hypertension - ...
Cached Medicine News:
(Date:1/15/2014)... Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, ... the Journal of Drugs in Dermatology (JDD) ... (ODAC). The event is January 17-20, 2014, at the Omni Orlando ... The ODAC is a distinguished event ...
(Date:1/15/2014)... Jan. 15, 2014  In an unprecedented effort to curb the spread ... and other transport vehicles, an advanced and portable UV germicidal lamp ... the first time. In order to prevent EMS ... pathogens, West Palm Beach Fire Rescue is ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading ... to release its second quarter 2011 financial results on Tuesday, ... financial markets.  The Company will also host a conference call ... 2011 to discuss its financial results and provide an update ...
... CHADDS FORD, Pa., June 30, 2011 Endo Pharmaceuticals (Nasdaq: ... phase 2 study comparing the novel investigational drug axomadol against ... chronic low back pain. The results indicate that axomadol did ... completing additional analyses of the data and evaluating the path ...
Cached Medicine Technology:Watson to Host Conference Call and Webcast to Discuss Second Quarter 2011 Earnings 2Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain 2
MagaCell-Streptavidin is a streptavidin coupled to magnetizable cellulose/iron oxide particles...
BioVintages Biotin-Trapper™ Streptavidin Magnetic Beads (1 mm - 2 mm) are designed for single-step capture of biotinylated molecules such as DNA, RNA or protein from cell lysates or hybridizatio...
... is a method for isolating antibodies, ... cells using affinity binding, while retaining ... on the particles to separate biotinylated ... the MagnaBind™ Beads from the suspension, ...
... m Dynabeads with covalently bound ... any biotinylated target. The Dynabeads® ... area, high capacity, magnetic pull ... during incubation. The MyOne™ products ...
Medicine Products: